[Agranulocytosis caused by dipyrone. Case reports].

Area of Science:

• Pharmacology
• Hematology
• Toxicology

Background:

• Dipyrone is a widely used analgesic and antipyretic medication.
• Agranulocytosis is a severe adverse drug reaction characterized by a drastic reduction in neutrophils.
• Understanding dipyrone's potential to induce agranulocytosis is crucial for patient safety.

Observation:

• Two distinct cases of dipyrone-induced agranulocytosis are presented.
• The first case resulted from a single dipyrone administration.
• The second case developed following prolonged dipyrone therapy.

Findings:

• The pathogenic mechanisms underlying dipyrone-induced agranulocytosis may involve immunologic and/or toxic pathways.
• The study discusses the efficacy of various therapeutic interventions and supportive care measures.
• Both single and prolonged exposure to dipyrone can precipitate this hematologic emergency.

Implications:

• Physician awareness and careful patient monitoring are essential for early detection and management.
• Effective patient health education regarding dipyrone risks can contribute to prevention.
• This highlights the importance of risk-benefit assessment for dipyrone use in clinical practice.